| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Shannon John Patrick Jr is a See Remarks at Xeris Biopharma Holdings, Inc.. Recent SEC Form 4 filings include 3 buys and 2 sells.
Estimated insider holdings value: $19.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sale+OE | 24,907 | $7.08 | $176,256.88 | -0.9% | -14.7% | - | |
| Nov 13, 2025 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sale+OE | 23,242 | $7.46 | $173,401.59 | -0.9% | -4.8% | - | |
| Nov 17, 2023 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Buy | 30,769 | $1.64 | $50,399.62 | +2.2% | +81.4% | +65.0% | |
| Nov 12, 2021 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Buy | 100,000 | $2.10 | $209,500.00 | +17.6% | +16.4% | -30.8% |